Amarin Corporation plc - American Depositary Shares (NQ:AMRN)

12.07 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amarin Corporation plc - American Depositary Shares

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Analyzing Amarin Corp's Unusual Options Activity ↗

August 05, 2021

Shares of Amarin Corp (NASDAQ:AMRN) saw some unusual opti...

Via Benzinga

Amarin (AMRN) Q2 2021 Earnings Call Transcript ↗

August 05, 2021

AMRN earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Recap: Amarin Q2 Earnings ↗

August 05, 2021

Shares of Amarin Corp (NASDAQ:AMRN) rose 0.7% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 100.00% over the...

Via Benzinga

Understanding Amarin Corp's Unusual Options Activity ↗

July 19, 2021

Shares of Amarin Corp (NASDAQ:AMRN) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved up to $4.22. Sentiment: BEARISH Option...

Via Benzinga

Why Amarin Fell Again Today ↗

June 22, 2021

Another Vascepa generic is launched in the U.S.

Via The Motley Fool

Topics Intellectual Property

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal ↗

June 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc...

Via Benzinga

48 Biggest Movers From Yesterday ↗

June 22, 2021

Gainers Lydall, Inc. (NYSE: LDL) shares jumped 85.4% to close at $61.72 on Monday after the company agreed to be acquired by Unifrax for $61.10 per share. New Concept Energy,...

Via Benzinga

Mid-Day Market Update: Crude Oil Rises 1.5%; Tarsus Pharmaceuticals Shares Slide ↗

June 21, 2021

Midway through trading Monday, the Dow traded up 1.48% to 33,782.47 while the NASDAQ rose 0.74% to 14,134.01. The S&P also rose, gaining 1.17% to 4,215.39. The U.S. has the...

Via Benzinga

Topics Stocks

31 Stocks Moving In Monday's Mid-Day Session ↗

June 21, 2021

Gainers Lydall, Inc. (NYSE: LDL) shares climbed 82.3% to $60.68 after the company agreed to be acquired by Unifrax for $61.10 per share. Raven Industries, Inc. (NASDAQ: RAVN)...

Via Benzinga

Why Amarin Stock Is Sinking Today ↗

June 21, 2021

The biotech's attempt to revive Vascepa's U.S. patent protection appears to be at a dead end.

Via The Motley Fool

Topics Intellectual Property

Understanding Amarin Corp's Unusual Options Activity ↗

June 09, 2021

Amarin Corp (NASDAQ:AMRN) shares experienced unusual options activity on Wednesday. The stock price moved up to $5.02 following the option alert. Sentiment: BEARISH Option Type...

Via Benzinga

Market Briefing For Tuesday, Jun. 8 ↗

June 08, 2021

Benign market behavior generally persists; as an out-of-the-box rally effort to start Monday was reversed, as is typical since traders want a pullback first.

Via Talk Markets

Why Amarin Trounced the Market on Tuesday ↗

May 18, 2021

Investors reacted positively to a company presentation at an industry convention.

Via The Motley Fool

Why Amarin Stock Is Tumbling Today ↗

May 12, 2021

An analyst downgraded the drugmaker.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2021 ↗

May 12, 2021

Upgrades Craig-Hallum upgraded the previous rating for ShotSpotter Inc (NASDAQ:SSTI) from Hold to Buy. For the first quarter, ShotSpotter had an EPS of $0.02, compared to...

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

May 12, 2021

HC Wainwright & Co. lowered Novavax, Inc. (NASDAQ: NVAX) price target from $317 to $294. Novavax shares fell 1.6% to $136.00 in pre-market trading. Needham cut BigCommerce...

Via Benzinga

Amarin (AMRN) Q1 2021 Earnings Call Transcript ↗

April 29, 2021

AMRN earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Amarin: Q1 Earnings Insights ↗

April 29, 2021

Shares of Amarin Corp (NASDAQ:AMRN) rose 2.5% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 100.00% over the past...

Via Benzinga

Cramer Weighs In On Paysafe, Xilinx And More ↗

April 15, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said Keysight Technologies Inc (NYSE: KEYS) has been just red hot and he really likes it. Amarin Corporation plc (...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 13, 2021

Gainers NovoCure (NASDAQ:NVCR) shares rose 42.08% to $187.38 during Tuesday's regular session. Trading volume for NovoCure's stock is 11.4 million as of 12:32 EST...

Via Benzinga

The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx ↗

April 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...

Via Benzinga

Why Amarin Stock Is Sinking Today ↗

April 13, 2021

The company's CEO announced his retirement.

Via The Motley Fool

The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx ↗

April 24, 2021

Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...

Via Benzinga

Should You Buy Amarin in April? ↗

April 09, 2021

This biotech's heart medication could be wildly lucrative.

Via The Motley Fool

50 Biggest Movers From Yesterday ↗

April 14, 2021

Gainers Mackinac Financial Corporation (NASDAQ: MFNC) shares surged 60.7% to close at $21.16 on Tuesday after the company, and Nicolet Bankshares, jointly announced the execution...

Via Benzinga

The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug ↗

April 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 12) 180 Life Sciences Corp. (...

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.